Sacubitril/valsartan versus enalapril on exercise capacity in patients with heart failure with reduced ejection fraction: A randomized, double-blind, active-controlled …
Background Sacubitril/valsartan reduces mortality in patients with heart failure with reduced
ejection fraction (HFrEF) when compared with enalapril. However, it is unknown the effect of …
ejection fraction (HFrEF) when compared with enalapril. However, it is unknown the effect of …
[引用][C] Sacubitril/valsartan versus enalapril on exercise capacity in patients with heart failure with reduced ejection fraction: A randomized, double-blind, active …
MR Santos, MJNN Alves, CP Jordão… - American heart …, 2021 - repositorio.usp.br
USP affiliated authors: SANTOS, MARCELO RODRIGUES DOS-FM; PEREIRA, ROSA
MARIA RODRIGUES-FM; NEGRÃO, CARLOS EDUARDO-EEFE; BARRETTO, ANTONIO …
MARIA RODRIGUES-FM; NEGRÃO, CARLOS EDUARDO-EEFE; BARRETTO, ANTONIO …
Sacubitril/valsartan versus enalapril on exercise capacity in patients with heart failure with reduced ejection fraction: A randomized, double-blind, active-controlled …
MR dos Santos, MJN Nunes Alves… - AMERICAN HEART …, 2021 - bv.fapesp.br
Background Sacubitril/valsar tan reduces mortality in patients with heart failure with reduced
ejection fraction (HFrEF) when compared with enalapril. However, it is unknown the effect of …
ejection fraction (HFrEF) when compared with enalapril. However, it is unknown the effect of …
Sacubitril/valsartan versus enalapril on exercise capacity in patients with heart failure with reduced ejection fraction: A randomized, double-blind, active-controlled …
MR SANTOS, MJNN ALVES… - American Heart …, 2021 - observatorio.fm.usp.br
Background Sacubitril/valsar tan reduces mortality in patients with heart failure with reduced
ejection fraction (HFrEF) when compared with enalapril. However, it is unknown the effect of …
ejection fraction (HFrEF) when compared with enalapril. However, it is unknown the effect of …
Sacubitril/valsartan versus enalapril on exercise capacity in patients with heart failure with reduced ejection fraction: A randomized, double-blind, active-controlled …
MR Dos Santos, MJNN Alves, CP Jordão, CEN Pinto… - 2021 - pubmed.ncbi.nlm.nih.gov
Sacubitril/valsartan reduces mortality in patients with heart failure with reduced ejection
fraction (HFrEF) when compared with enalapril. However, it is unknown the effect of both …
fraction (HFrEF) when compared with enalapril. However, it is unknown the effect of both …
Sacubitril/valsartan versus enalapril on exercise capacity in patients with heart failure with reduced ejection fraction: A randomized, double-blind, active-controlled …
MR Dos Santos, MNN Alves, CP Jordão… - American Heart …, 2021 - europepmc.org
Methods We included 52 participants with HFrEF with a left ventricular ejection fraction<
40% to receive either sacubitril/valsartan (target dose of 400 mg daily) or enalapril (target …
40% to receive either sacubitril/valsartan (target dose of 400 mg daily) or enalapril (target …
Sacubitril/valsartan versus enalapril on exercise capacity in patients with heart failure with reduced ejection fraction: A randomized, double-blind, active-controlled …
MR dos Santos, MJN Nunes Alves… - AMERICAN HEART …, 2021 - bv.fapesp.br
Background Sacubitril/valsar tan reduces mortality in patients with heart failure with reduced
ejection fraction (HFrEF) when compared with enalapril. However, it is unknown the effect of …
ejection fraction (HFrEF) when compared with enalapril. However, it is unknown the effect of …